Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic, threatening global public health. In the current paper, we describe our successful treatment of one COVID-19 pneumonia patient case with high mortality risk fac...
Main Authors: | Pietro Sodani, Luciano Mucci, Rita Girolimetti, Silvia Tedesco, Francesca Monaco, Daniele Campanozzi, Marino Brunori, Stefania Maltoni, Samuele Bedetta, Anna M. Di Carlo, Piero Candoli, Mauro Mancini, Alberto Rebonato, Francesca D'Adamo, Maria Capalbo, Gabriele Frausini |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120302574 |
Similar Items
-
Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01) -
Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure
by: Antoniadou, C., et al.
Published: (2022) -
Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir
by: Naohiro Oda, et al.
Published: (2021-07-01) -
Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation
by: Castle RD, et al.
Published: (2021-09-01) -
Baricitinib exposure during pregnancy in rheumatoid arthritis
by: Giulia Costanzo, et al.
Published: (2020-01-01)